Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
zelenirstat (PCLX-001) / Pacylex Pharmaceuticals
NCT04836195: Study of PCLX-001 in R/R Advanced Solid Malignancies and B-cell Lymphoma	Recruiting	1	60	Canada	PCLX-001	Pacylex Pharmaceuticals, Ozmosis Research Inc.	B-cell Non Hodgkin Lymphoma, Advanced Solid Tumor	10/24	12/24
NCT06613217: Study of Oral PCLX-001 in R/R Acute Myeloid Leukemia	Not yet recruiting	1	35	NA	zelenirstat, PCLX-001	Pacylex Pharmaceuticals, Ozmosis Research Inc., United States Department of Defense	Relapsed Adult AML	03/26	09/26